prostate cancer

Wilmington, Delaware, United States, June 23, 2023 (GLOBE NEWSWIRE) -- The global brachytherapy seeds market is estimated to flourish at a CAGR of 4.1% from 2023 to 2031. According to…

NEW HAVEN, Conn., June 15, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein…

If approved for Europe, PYLCLARI® (INN: Piflufolastat (18F) formerly known as -DCFPyL) will offer prostate cancer patients access to a diagnostic imaging agent more sensitive than…

<!-- Name:DistributionId Value:1000809937 --> <!-- Name:NewsArchiveTags Value:MyWeb -->…

With about two dozen chemotherapy drugs in short supply, oncology ranks in the top five clinical areas most affected…

<!-- Name:DistributionId Value:8788081 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8783415 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

In October 2018, guitarist and founding member of Duran Duran Andy Taylor was riding high.…

Note that some links may require subscriptions. Veterinarians and researchers are warning…

Excluding systematic biopsy in favor of MRI-targeted biopsy in men with elevated…